Covance Inc.
and
BML, Inc
., a Japanese laboratory testing company, today announced the expansion of the Covance-BML Clinical Trial Laboratory (CB Trial Lab) in Kawagoe City, Saitama Prefecture to enhance the capacity and capabilities in the region. The companies, which opened the lab together in 2010 as part of a five-year agreement, will launch several new expansion-related services this month.
“The expansion of the CB Trial Lab speaks to both the success of our affiliation with BML and the growing drug development relationships we have built with our clients in Japan and across the Asia-Pacific region,” said Jonathan Koch, Global General Manager, Covance Central Laboratory Services.
“This investment is an important step in growing our relationship with Covance and allows us to offer clients a wider range of services in anincreasingly competitive marketplace,” said Kazuta Fukuda, President,BML.
The lab expansion includes increasing the size of the original facility by 50 percent, while adding new testing platforms, equipment and additional sample storage space. Specifically, new laboratory testing platforms have been added to enhance the capacity of the CB Trial Lab to manage the growing demand for in-country testing services. These new service offerings in the areas of immunoassay, flow cytometry, and protein chemistry will speed results to physicians conducting clinical trials for these critical testing parameters.
The CB Trial Laboratory is accredited by the College of American Pathologists (CAP), and maintains CDC lipid certification as well as National Glycohemoglobin Standardization Program (NGSP) Level 1 certification.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.